Heartcare Pharma Services Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 17 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.40 Cr
- Revenue Growth 38.98%
- Profit Growth -49.54%
- Ebitda 152.92%
- Net Worth 81.86%
- Total Assets -28.30%
About Heartcare Pharma Services
Heartcare Pharma Services Private Limited (HPSPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 July 2007 and has a history of 17 years and seven months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹2.40 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Seema Subil and Subil Prabhu serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232MH2007PTC172367
- Company No.
172367
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jul 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Heartcare Pharma Services?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subil Prabhu  | Director | 14-Jan-2015 | Current |
| Seema Subil | Director | 14-Jul-2007 | Current |
Financial Performance of Heartcare Pharma Services.
Heartcare Pharma Services Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 38.98% increase. The company also saw a substantial fall in profitability, with a 49.54% decrease in profit. The company's net worth Soared by an impressive increase of 81.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Heartcare Pharma Services?
In 2020, Heartcare Pharma Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Heartcare Infotech LlpSeema Subil and Subil Prabhu are mutual person
Charges (Loans)
₹0
₹24.00 M
Charges Breakdown by Lending Institutions
- The Saraswat Co-Op Bank Ltd : 2.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Oct 2007 | The Saraswat Co-Op Bank Ltd | ₹2.40 Cr | Satisfied |
How Many Employees Work at Heartcare Pharma Services?
Unlock and access historical data on people associated with Heartcare Pharma Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Heartcare Pharma Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Heartcare Pharma Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
